The Top 3 Questions Looming Over Pharma Sector This 2023
2023 can be challenging for the pharmaceutical sector as it will mark the rollout of certain important drug pricing reforms across the US which...
FDA Comes With A Research Map Concerning Biosimilars Program
The FDA has gone on to release the Biosimilar User Fee Amendments III Regulatory Science Pilot Program, called the Research Roadmap, to give out...
Getting Immunotherapy Work In Case of Pancreatic Cancer
One of the latest studies that takes into account the tumour microenvironment of pancreatic cancer puts forth the cause that tumour cells are resistant...
Monoclonal Antibodies Ideal Against Malaria- Suggests Study
Only one dose of the monoclonal antibody (mAb) CIS43LS gave out high levels of protection against Malaria in challenge study as per new research....
A New UK Manufacturing Regulatory Framework On The Cards
As UK will introduce a customised framework for the innovative medicines’ regulation manufactured at the point where the care is received by the patient,...
With Discovery, Skullcap A Perfect Fit For Modern Medicine
A collaboration between Chinese researchers and UK researchers has led to the unlocking of facilities related to evolutionary secrets that help the medicinal herb...
New Algorithms That Lead To Personalized Cancer Treatments
When single-cell data is combined with a self-learning algorithm, it is a revelation as to how structural changes can go on to trigger cancer....
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...